Nimwesiga Christine, Taremwa Ivan Mugisha, Nakanjako Damalie, Nasuuna Esther
Uganda Nurses and Midwives Council, Ministry of Health, Kampala, Uganda.
Infectious Diseases Institute, Kampala, Uganda.
HIV AIDS (Auckl). 2023 Mar 4;15:71-81. doi: 10.2147/HIV.S401611. eCollection 2023.
Retention in antiretroviral therapy (ART) care is a key indicator of Human Immunodeficiency Virus (HIV) treatment success as it improves adherence, critical for better treatment outcomes and prevention of drug resistance. HIV treatment among adolescents living with HIV (ALHIV) is characterized by loss to follow-up, poor ART adherence, and eventual death. This study assessed retention in ART care and the associated factors among ALHIV in Ibanda district, rural South Western Uganda.
This was a retrospective cohort study using clinical data from ALHIV enrolled from 2019 to 2020 in eight health facilities in Ibanda district. Data from the Electronic Medical Record (EMR) system was extracted to assess the associated factors and participants' status two years after enrollment. Data were analyzed using EPIdata version 3.1 in which Univariate and multivariate cox proportional hazard regression analyses were determined. A hazard ratio (HR) at a 95% confidence interval was obtained, and a P-value <0.05 was considered statistically significant.
Eighty-four ALHIV comprising 86.9% (N = 73) females were enrolled. The majority 63.1% (N = 53) resided in semi/peri-urban, and 44.0% (N = 37) stayed less than 5 km from the facility. Only 35.7% (N = 30) were active on ART, while 17 (20.2%) and 36 (42.9%) were lost to follow-up and transfer-outs, respectively. Factors associated with low retention were: ALHIV that moved 5-10Km (HR = 5.371; 95% CI: 1.227-23.5050, p = 0.026), used differential service delivery model was Facility-Based Group (FBG) (HR = 12.419; 95% CI: 4.034-38.236, p < 0.001) and those enrolled on the Young Adolescent Program Support (YAPs) (HR = 4.868; 95CI:1.851-12.803; p = 0.001). Retention reduced with increasing ART duration, ALHIV on (TDF/3TC/EFV) (p < 0.001), lived more than 10Km (p = 0.043) and did not benefit from any intervention (p < 0.001).
Results showed low retention in care and the urgent need to strengthen individual case management strategies for ALHIV, thus interventions focusing on peer support are desired.
坚持接受抗逆转录病毒治疗(ART)是人类免疫缺陷病毒(HIV)治疗成功的关键指标,因为它能提高依从性,而依从性对于获得更好的治疗效果和预防耐药性至关重要。感染HIV的青少年(ALHIV)的HIV治疗存在失访、ART依从性差以及最终死亡等问题。本研究评估了乌干达西南部农村伊班达区ALHIV的ART治疗留存率及其相关因素。
这是一项回顾性队列研究,使用了2019年至2020年在伊班达区8个卫生机构登记的ALHIV的临床数据。从电子病历(EMR)系统中提取数据,以评估相关因素以及入组两年后参与者的状态。使用EPIdata 3.1版软件进行数据分析,确定单因素和多因素Cox比例风险回归分析。获得95%置信区间的风险比(HR),P值<0.05被认为具有统计学意义。
共纳入84名ALHIV,其中86.9%(N = 73)为女性。大多数(63.1%,N = 53)居住在半城市/城郊地区,44.0%(N = 37)居住在距离医疗机构不到5公里的地方。只有35.7%(N = 30)积极接受ART治疗,而分别有17名(20.2%)和36名(42.9%)失访和转出。与低留存率相关的因素有:居住地址变动5 - 10公里的ALHIV(HR = 5.371;95%CI:1.227 - 23.5050,p = 0.026)、采用基于机构的小组(FBG)差异化服务提供模式(HR = 12.419;95%CI:4.034 - 38.236,p < 0.001)以及参加青少年项目支持(YAPs)的(HR = 4.868;95%CI:1.851 - 12.803;p = 0.001)。留存率随着ART治疗持续时间的增加而降低,接受(替诺福韦/拉米夫定/依非韦伦)(TDF/3TC/EFV)治疗的ALHIV(p < 0.001)、居住距离超过10公里的(p = 0.043)以及未从任何干预措施中受益的(p < 0.001)。
结果显示治疗留存率较低,迫切需要加强针对ALHIV的个体病例管理策略,因此需要开展侧重于同伴支持的干预措施。